Showing 8,426 results

Filters Content type: News, Editors' picks Country: Sub-Saharan Africa
New & experimental hepatitis C treatment

Grading Hep C Stocks Exiting EASL - The future of hepatitis C therapy belongs to interferon-free regimens

Editor's pick
The Street
23 April 2012
Money

UK: HIV specialist social worker posts maintained in face of cuts

Editor's pick
Community Care
23 April 2012
New & experimental hepatitis C treatment

Achillion Announces 94 - 100% Complete EVR From Phase 2 Trial With ACH-1625 Based Regimen in Hepatitis C

Editor's pick
Achillion (press release)
23 April 2012
New & experimental hepatitis C treatment

Achillion Clarifies End of Treatment Data From Phase 2a Trial With ACH-1625 Based Regimen in Hepatitis C

Editor's pick
Achillion (press release)
23 April 2012
PrEP

The 100 Most Influential People in the World: Robert Grant

Editor's pick
Time
23 April 2012
Access to healthcare

Kenya: UNAIDS welcomes High Court judgment on anti-counterfeit law

Editor's pick
UNAIDS
20 April 2012
New & experimental hepatitis C treatment

J&J Open to Expanding Hepatitis C Collaboration With Vertex

Editor's pick
HCV New Drugs Research
20 April 2012
New & experimental hepatitis C treatment

Pancreatitis Forces Halt to HCV Drug Trial

Editor's pick
MedPage Today
20 April 2012
New & experimental hepatitis C treatment

Janssen Creates new Division to Launch TMC435 and Help Conquer Hepatitis C in EMEA

Editor's pick
Janssen press release
20 April 2012
New & experimental HIV treatments

Cobicistat Doubles to Triples Exposure of GS-7340 (a Tenofovir Prodrug) and Resulting Tenofovir

Editor's pick
NATAP
20 April 2012
Undetectable viral load & treatment as prevention

Guidance on couples HIV testing and counselling, including antiretroviral therapy for treatment and prevention in serodiscordant couples

Editor's pick
World Health Organization
20 April 2012
New & experimental hepatitis C treatment

No Relevant Interactions Between Telaprevir and Two Newest Nonnucleosides Rilpivirine & Etravirine

Editor's pick
NATAP
20 April 2012
New & experimental hepatitis C treatment

Medivir Hep C Drug Cures 80% of Patients Post-Treatment

Editor's pick
Bloomberg BusinessWeek
20 April 2012
New & experimental hepatitis C treatment

Investigational Compound Peginterferon Lambda Achieved SVR24 Rates Comparable to Peginterferon Alfa with Fewer Flu-Like and Musculoskeletal Symptoms in Phase IIb Study in Treatment-Naive Genotype 2 or 3 Hepatitis C Patients

Editor's pick
BMS press release
20 April 2012
New & experimental hepatitis C treatment

Gilead’s Experimental Hepatitis C Drug Cured 88% Post-Therapy

Editor's pick
Bloomberg
20 April 2012
New & experimental hepatitis C treatment

Boehringer Ingelheim Hepatitis C Drugs Cured 82% in Trial

Editor's pick
Bloomberg
20 April 2012
New & experimental hepatitis C treatment

Gilead, Bristol hepatitis C trial data impresses

Editor's pick
Reuters
20 April 2012
Global health initiatives

Can the Global Fund's new management change its fortunes?

Editor's pick
The Guardian
20 April 2012
New & experimental hepatitis C treatment

Gilead, Bristol-Myers Squibb Put Profits Ahead of Best Care for Hep C Patients

Editor's pick
The Street
20 April 2012
Global health initiatives

US Reveals Nearly $1.5 Billion in Unspent AIDS Money

Editor's pick
Global Post
19 April 2012
New & experimental hepatitis C treatment

EASL-Anemia Management Strategies Used With VICTRELIS® (boceprevir) Combination Therapy

Editor's pick
HCV New Drugs Research
19 April 2012
New & experimental hepatitis C treatment

EASL-Abbott Presents Positive Results from Interferon-Free Phase 2 "Co-Pilot" Study for the Treatment of Hepatitis C-ABT-450/r, plus ABT-333 and ribavirin

Editor's pick
HCV New Drugs Research
19 April 2012
Testing & health monitoring

Testing, Counseling Of Cocaine And Heroin Users Reduces Unprotected Sex

Editor's pick
HIV / AIDS News From Medical News Today
19 April 2012

Global Fund: A Rogues' Gallery

Editor's pick
IRIN
19 April 2012